retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Today, we shared new data from two trials of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v PDB-101: Molecule of the Month:

In the past 2 years, two novel pathways unrelated to GPX4 have been discovered to inhibit lipid peroxidation associated with ferroptosis

DOI: 10.1111/j.1537-2995.2010.03032.x 94

The injection is administered intramuscularly or subcutaneously, typically 1-2 times per week as directed by your provider

For the US, that was pretty progressive if you're over in Europe, not so progressive because they've been using them for almost 50 years in humans

The most common type used in UK pharmacies is hydroxocobalamin , which is the version recommended by the NHS for treating B12 deficiency

Table 1 Proposed multi-drug approach for either the prophylaxis for high risk population, and treatment of mild and severe cases